Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, Shanghai, People's Republic of China.
J Proteome Res. 2010 Jun 4;9(6):3225-34. doi: 10.1021/pr1001274.
This study investigated the mechanisms involved in the antinociceptive action induced by levo-tetrahydropalmatine (l-THP) in the formalin test by combined comparative and chemical proteomics. Rats were pretreated with l-THP by the oral route (40 mg/kg) 1 h before formalin injection. The antinociceptive effect of l-THP was shown in the first and second phases of the formalin test. To address the mechanisms by which l-THP inhibits formalin-induced nociception in rats, the combined comparative and chemical proteomics were applied. A novel high-throughput comparative proteomic approach based on 2D-nano-LC-MS/MS was applied to simultaneously evaluate the deregulated proteins involved in the response of l-THP treatment in formalin-induced pain rats. Thousands of proteins were identified, among which 17 proteins survived the stringent filter criteria and were further included for functional discussion. Two proteins (Neurabin-1 and Calcium-dependent secretion activator 1) were randomly selected, and their expression levels were further confirmed by Western Blots. The results matched well with those of proteomics. In the present study, we also described the development and application of l-THP immobilized beads to bind the targets. Following incubation with cellular lysates, the proteome interacting with the fixed l-THP was identified. The results of comparative and chemical proteomics were quite complementary. Although the precise roles of these identified moleculars in l-THP-induced antinociception need further study, the combined results indicated that proteins associated with signal transduction, vesicular trafficking and neurotransmitter release, energy metabolism, and ion transport play important roles in l-THP-induced antinociception in the formalin test.
本研究通过比较蛋白质组学和化学蛋白质组学相结合的方法,探讨左旋四氢巴马汀(l-THP)在福尔马林试验中诱导抗伤害作用的机制。大鼠在福尔马林注射前 1 小时通过口服途径给予 l-THP(40mg/kg)预处理。l-THP 在福尔马林试验的第一和第二阶段显示出抗伤害作用。为了探讨 l-THP 抑制大鼠福尔马林诱导疼痛的机制,应用了比较蛋白质组学和化学蛋白质组学的联合方法。应用一种基于 2D-nano-LC-MS/MS 的新型高通量比较蛋白质组学方法,同时评估参与 l-THP 处理大鼠福尔马林诱导疼痛反应的失调蛋白。鉴定了数千种蛋白质,其中 17 种蛋白质通过严格的过滤标准,并进一步纳入功能讨论。随机选择了两种蛋白质(Neurabin-1 和钙依赖性分泌激活因子 1),并通过 Western Blots 进一步确认其表达水平。结果与蛋白质组学结果吻合良好。在本研究中,我们还描述了 l-THP 固定珠的开发和应用,以结合靶标。与细胞裂解物孵育后,鉴定与固定 l-THP 相互作用的蛋白质组。比较蛋白质组学和化学蛋白质组学的结果非常互补。尽管这些鉴定的分子在 l-THP 诱导镇痛中的确切作用需要进一步研究,但联合结果表明,与信号转导、囊泡运输和神经递质释放、能量代谢和离子转运相关的蛋白质在 l-THP 诱导的福尔马林试验中的镇痛作用中发挥重要作用。